SHAREHOLDERS' EQUITY |
6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| SHAREHOLDERS' EQUITY | NOTE 4 – SHAREHOLDERS’ EQUITY:
During the three months ended June 30, 2026, the Company sold a total of 14,295 common shares under its At-the-Market Offering Agreement (the “ATM Program”) for aggregate total gross proceeds of approximately $0.2 million at an average selling price of $12.51 per share, resulting in net proceeds of approximately $0.2 million after deducting issuance costs. During the six months ended June 30, 2026, the Company sold a total of 15,126 common shares under its ATM Program for aggregate gross proceeds of approximately $0.2 million at an average selling price of $12.33 per share, resulting in net proceeds of approximately $0.2 million after deducting issuance costs. As of June 30, 2026, approximately $34.8 million of securities remain available for sale under the ATM Program.
During February 2025, the Company completed a public offering in which it sold 3,105,000 shares of common stock at $5.00 per share, receiving net proceeds of $14.0 million after deducting underwriting discounts and commissions of $1.1 million and other offering expenses of $0.4 million. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|